Skip to main content
. 2008 Sep;57(9):2348–2359. doi: 10.2337/db07-1736

TABLE 1.

Allele frequencies in DPT-1 participants and comparative cohorts

Chromosome Gene name Polymorphism Alleles
rs number Allele counts 0/1/2
MAF
OR (95% CI) P value Control subjects MAF
Case subjects MAF
0 1 Nonprogressor Progressor Nonprogressor Progressor Lit. HapMap CEU DCGS Lit. DCGS
6 Lymphotoxin-α +10 G A rs1800683 137/173/39 115/95/17 0.36 0.28 1.41 (1.1–1.83) 9.4E–03 0.36 0.34 0.44
11 Insulin −23 Hphl T A rs689 16/109/221 7/63/153 0.20 0.17 1.23 (0.9–1.67) 0.22 0.32 0.24 0.28 0.12 0.18
1 PTPN22 R620W C T rs2476601 253/86/9 155/66/6 0.15 0.17 1.18 (0.86–1.63) 0.35 0.06–0.15 0.14 0.08 0.15–0.17 0.19
10 IL-2 Ra (CD25) Intron 1 G A rs706778 106/175/64 57/124/45 0.44 0.47 1.15 (0.91–1.46) 0.28 00.4–0.45 0.45 0.39* 0.45 0.48*
10 IL-2 Ra (CD25) Intron 1 T C rs3118470 145/160/41 85/115/26 0.35 0.37 1.09 (0.8–1.39) 0.54 0.32–0.34 0.29 0.25* 0.36 0.38*
10 IL-2 Ra (CD25) IL-2 Ra region C A rs41295061 307/36/5 194/28/1 0.07 0.07 1.02 (0.63–1.64) 0.96 0.11 0.07
10 IL-2 Ra (CD25) IL-2 Ra region T A rs11594656 204/119/20 141/67/13 0.23 0.21 1.13 (0.85–1.51) 0.44 0.25 0.21 0.22
2 IFIH1 A946T C T rs1990760 43/139/143 25/104/93 0.35 0.35 1.00 (0.78–1.29) 0.97 0.39 0.39 0.35
1 Fc receptor-like 3 Prom −169 A G rs7528684 99/174/67 74/107/42 0.45 0.43 1.11 (0.87–1.41) 0.45 0.45 0.44 0.49 0.44
6 C6orf118 M256I C A rs510579 144/158/42 88/111/25 0.35 0.36 1.03 (0.81–1.33) 0.84 0.35 0.36 0.38
5 CAPSL R75Q A G rs1445898 55/184/94 41/103/68 0.44 0.44 1.02 (0.8–1.31) 0.92 0.44 0.39 0.41
2 CTLA4 Prom −1577 G A rs11571316 129/176/42 90/102/32 0.37 0.37 1.02 (0.8–1.3) 0.94 0.42 0.47 0.46 0.35 0.42
2 CTLA4 Prom −318 T C rs5742909 0/60/278 2/34/188 0.09 0.08 1.05 (0.69–1.61) 0.90 0.11 0.06 0.06 0.09 0.08
2 CTLA4 T49A G A rs231775 57/175/111 43/115/66 0.42 0.45 1.12 (0.88–1.42) 0.40 0.43 0.38 0.38 0.29 0.42
2 CTLA4 3'UTR 6230 (CT60) G A rs3087243 117/181/48 84/105/35 0.40 0.39 1.04 (0.82–1.33) 0.79 0.48 0.46 0.47 0.37 0.43
2 CTLA4 JO31 C A rs11571302 101/176/47 74/108/38 0.42 0.42 1.01 (0.79–1.29) 0.99 0.50 0.49 0.39 0.47
2 CD28 Intron 1 C T rs10932017 74/182/90 43/116/64 0.48 0.45 1.10 (0.87–1.4) 0.47 0.44 0.42 0.43 0.45
2 CD28 Intron 1 A T rs2013278 39/145/148 25/98/97 0.34 0.34 1.00 (0.78–1.29) 0.96 0.36 0.23 0.26
2 CD28 3′UTR G T rs3181113 313/35/0 211/11/1 0.05 0.03 1.76 (0.92–3.37) 0.11 0.03 0.03 0.04 0.02
2 CD28 3′UTR T A rs11681201 22/117/210 12/87/128 0.23 0.24 1.08 (0.82–1.42) 0.64 0.13 0.20 0.15 0.18
2 ICOS Prom −1817 T C rs4452124 263/76/5 182/38/2 0.13 0.09 1.37 (0.93–2.02) 0.14 0.08 0.06 0.08 0.07
2 ICOS Intron 1 C T rs4335928 0/79/269 4/52/170 0.11 0.13 1.20 (0.84–1.71) 0.38 0.11 0.10 0.10 0.13 0.12
2 ICOS Intron 1 C T rs4675377 20/146/179 13/92/121 0.27 0.26 1.04 (0.8–1.37) 0.80 0.17 0.18 0.22 0.26
12 VDR BsmI Intron3 T C rs1544410 142/146/56 86/99/38 0.38 0.39 1.08 (0.84–1.37) 0.60 0.12–0.25 0.44 0.38 0.12–0.23 0.38
4 TLR2 S450S T C rs3804100 302/38/1 197/25/2 0.06 0.06 1.11 (0.68–1.82) 0.77 0.41 0.05 0.07 0.39 0.07
19 KIR 2DS3 Abs Pres 252/80/0 158/60/0 0.12 0.14 1.16 (0.81–1.67) 0.46 0.38 0.32 0.21 0.41
10 TCF7L2 Intron 3 C T rs7903146 182/134/31 115/90/21 0.28 0.29 1.05 (0.81–1.36) 0.78 0.29 0.25 0.31 0.41 0.30
8 SLC30A8 R325W C T rs13266634 187/131/30 116/86/24 0.27 0.30 1.11 (0.86–1.45) 0.46 0.30 0.25 0.29 0.25 0.31
10 HHEX HHEX region A G rs7923837 48/160/136 33/112/81 0.37 0.39 1.10 (0.86–1.4) 0.50 0.38 0.38 0.37 0.34 0.40
10 HHEX HHEX region G A rs1111875 115/179/54 73/108/45 0.41 0.44 1.11 (0.87–1.41) 0.42 0.40 0.44 0.39 0.36 0.41
11 LOC387761 Intron 5 G A rs7480010 189/139/21 115/92/19 0.26 0.29 1.15 (0.88–1.5) 0.32 0.30 0.25 0.30 0.34 0.32
11 EXT2 Intron 14 A G rs3740878 200/124/21 119/96/11 0.24 0.26 1.12 (0.85–1.47) 0.48 0.27 0.30 0.27 0.24 0.27
12 ERBB2 Intron 7 A C rs2292239 46/191/109 35/100/90 0.41 0.38 1.14 (0.89–1.45) 0.32 0.36 0.30 0.41
18 PTPN2 Intron 7 T C rs1893217 236/101/8 149/62/14 0.17 0.20 1.22 (0.9–1.66) 0.22 0.17 0.19 0.21
12 SH2B3 Exon 3 C T rs3184504 85/168/89 54/111/58 0.49 0.49 1.01 (0.8–1.29) 0.97 0.49 0.41 0.56
12 C12Orf30 Intron 15 A G rs17696736 99/174/72 72/105/47 0.46 0.44 1.07 (0.84–1.36) 0.62 0.43 0.35 0.49
16 CLEC16A Intron 19 A G rs12708716 160/147/33 100/90/30 0.31 0.34 1.13 (0.88–1.46) 0.37 0.35 0.29 0.31
*

Allele frequencies from the Diabetes in Adolescents and the Very Young (DAVY) study (31).

Allele frequency in Koreans. Abs, absent; MAF, minor allele frequency; Pres, present.